NCI principal deputy director receives award for achievement in cancer research
Click Here to Manage Email Alerts
Douglas R. Lowy, MD, FAACR, will receive this year’s AACR-Margaret Foti Award for Leadership and Extraordinary Achievements in Cancer Research.
The award, presented at this year’s American Association for Cancer Research Annual Meeting, is given to an individual whose leadership and extraordinary achievements in cancer research have made a major impact in the field.
Lowy is principal deputy director at NCI, as well as chief of its Laboratory of Cellular Oncology and head of the signaling and oncogenesis section. He served as acting director of NCI from 2015 to 2017.
The award recognizes Lowy for his leadership at NCI, his research that contributed to the development of three FDA-approved HPV vaccines, and his contributions to the NIH’s response to the COVID-19 pandemic.
“Dr. Lowy’s commitment to public service and public health is highly commendable,” Margaret Foti, PhD, MD (hc), CEO of AACR, said in an association-issued press release. “His leadership and scientific accomplishments have undoubtedly saved lives. As a result of his research, we have highly effective HPV vaccines that can prevent several types of cancer. Moreover, his work at the NCI as principal deputy director and previously as acting director has helped the agency to remain at the forefront of cancer research and care.”
Read more about
Click Here to Manage Email Alerts